Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NAMSNewAmsterdam Pharma Co N.V.

Nasdaq · CIK 0001936258
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts295

Identity from submissions API

NameNewAmsterdam Pharma Co N.V.
CIK0001936258
TickersNAMS, NAMSW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationP7 Netherlands
Phone35 206 2971
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • NewAmsterdam Pharma Co B.V. (2022-08-04T04:00:00.000Z → 2022-11-22T05:00:00.000Z)
Business address
GOOIMEER 2-35
NARRDEN
P7
1411 DC
Netherlands
Mailing address
GOOIMEER 2-35
NARRDEN
P7
1411 DC
Netherlands

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

417 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000287 005-93833 261562839 34 15731
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000277 005-93833 261558575 34 12907
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002799 005-93833 261526268 34 11723
2026-11-04 10-Q 10-Q 0001193125-26-446228 001-41562 261520075 34 9301889 1 1
2026-11-04 8-K 8-K 9.01 0001193125-26-446219 001-41562 261520069 34 1011546 1 1
2026-10-02 4 4 0001193125-26-412431 11811
2026-09-29 8-K 8-K 8.01,9.01 0001193125-26-406063 001-41562 261419223 34 243085 1 1
2026-09-22 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001231919-26-001215 005-93833 261397484 34 108503
2026-09-21 8-K 8-K 8.01 0001193125-26-396716 001-41562 261394294 34 207400 1 1
2026-09-15 4 4 0001193125-26-391985 19348
2026-09-09 4 4 0001193125-26-386508 18708
2026-09-03 4 4 0001193125-26-381953 7625
2026-08-25 144/A xsl144X01/primary_doc.xml 0001968582-26-000878 001-41562 261316476 33 5122
2026-08-25 4 4 0001193125-26-365202 24448
2026-08-24 144 xsl144X01/primary_doc.xml 0001968582-26-000868 001-41562 261311373 33 5016
2026-08-14 8-K/A 8-K/A 5.02 0001193125-26-352233 001-41562 261281576 34 213961 1 1
2026-08-14 3 3 0001193125-26-352209 17239
2026-08-14 8-K 8-K 5.02 0001193125-26-352186 001-41562 261281211 34 207059 1 1
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002082 005-93833 261247159 34 11713
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-333827 001-41562 261241313 34 868204 1 1
2026-08-05 10-Q 10-Q 0001193125-26-333824 001-41562 261241304 34 7749691 1 1
2026-07-24 8-K 8-K 8.01,9.01 0001193125-26-315163 001-41562 261198488 34 249816 1 1
2026-07-22 8-K 8-K 5.02 0001193125-26-312390 001-41562 261193741 34 202230 1 1
2026-07-22 4 4 0001193125-26-312387 16874
2026-06-24 4 4 0001193125-26-281062 14435
2026-06-05 S-8 S-8 0001193125-26-259794 333-296554 261069870 33 481913 1 1
2026-06-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000108 005-93833 261066367 34 7637
2026-06-03 8-K 8-K 5.02,5.07,9.01 0001193125-26-254615 001-41562 261058946 34 465704 1 1
2026-05-27 4 4 0001193125-26-241983 13079
2026-05-26 144 xsl144X01/primary_doc.xml 0001968582-26-000491 001-41562 261020961 33 4979
2026-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-224656 005-93833 26981463 34 16332
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210283 001-41562 26950777 34 714298 1 1
2026-05-07 10-Q 10-Q 0001193125-26-210272 001-41562 26950759 34 7473671 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001273 005-93833 26946888 34 11332
2026-05-06 ARS ARS 0001193125-26-207564 001-41562 26945811 34 3080512
2026-05-06 DEF 14A DEF 14A 0001193125-26-207562 001-41562 26945805 34 6340837 1 1
2026-04-24 8-K 8-K 5.02 0001193125-26-177406 001-41562 26894759 34 202720 1 1
2026-04-20 PRE 14A PRE 14A 0001193125-26-162757 001-41562 26873380 34 5676876 1 1
2026-03-12 4 4 0001193125-26-104239 6751
2026-03-11 144 xsl144X01/primary_doc.xml 0001968582-26-000272 001-41562 26743356 33 5128
2026-03-10 4 4 0001193125-26-100798 8700
2026-03-09 4 4 0001193125-26-099073 22016
2026-03-06 144 xsl144X01/primary_doc.xml 0001968582-26-000241 001-41562 26732531 33 7721
2026-03-05 144 xsl144X01/primary_doc.xml 0001968582-26-000230 001-41562 26726277 33 4651
2026-03-02 4 4 0001193125-26-085947 8608
2026-03-02 144 xsl144X01/primary_doc.xml 0001968582-26-000187 001-41562 26707666 33 7044
2026-03-02 8-K 8-K 7.01,9.01 0001193125-26-084266 001-41562 26703533 34 18537143 1 1
2026-02-26 4 4 0001193125-26-078718 28132
2026-02-24 4 4 0001193125-26-067260 6893
2026-02-24 144 xsl144X01/primary_doc.xml 0001968582-26-000152 001-41562 26671941 33 4649
2026-02-20 144 xsl144X01/primary_doc.xml 0002085929-26-000002 001-41562 26656690 33 5069
2026-02-18 S-8 S-8 0001193125-26-056037 333-293540 26645399 33 555545 1 1
2026-02-18 10-K 10-K 0001193125-26-056029 001-41562 26645384 34 18359026 1 1
2026-02-18 8-K 8-K 2.02,9.01 0001193125-26-056020 001-41562 26645379 34 862013 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-26-000880 005-93833 26642025 34 39683
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000486 005-93833 26601969 34 11378
2026-01-29 4 4 0001193125-26-029526 13976
2026-01-27 4 4 0001193125-26-025012 17663
2026-01-22 4 4 0001193125-26-019686 19694
2026-01-20 144 xsl144X01/primary_doc.xml 0001968582-26-000040 001-41562 26543057 33 4575
2026-01-09 4 4 0001193125-26-009274 7235
2026-01-09 4 4 0001193125-26-009273 7174
2026-01-09 4 4 0001193125-26-009272 9549
2026-01-09 4 4 0001193125-26-009271 7138
2026-01-09 4 4 0001193125-26-009270 7210
2026-01-09 4 4 0001193125-26-009269 7156
2026-01-09 4 4 0001193125-26-009268 7742
2026-01-09 8-K 8-K 2.02,7.01,9.01 0001193125-26-008300 001-41562 26521375 34 269755 1 1
2026-01-07 4 4 0001193125-26-006662 9661
2026-01-07 4 4 0001193125-26-006659 9583
2026-01-07 4 4 0001193125-26-006658 9609
2026-01-07 144 xsl144X01/primary_doc.xml 0001974494-26-000023 001-41562 26514976 33 4477
2026-01-06 144 xsl144X01/primary_doc.xml 0001968582-26-000015 001-41562 26512019 33 4607
2026-01-05 144 xsl144X01/primary_doc.xml 0001974494-26-000017 001-41562 26505463 33 5119
2026-01-05 144 xsl144X01/primary_doc.xml 0001974494-26-000015 001-41562 26505392 33 4497
2026-01-05 144 xsl144X01/primary_doc.xml 0001974494-26-000013 001-41562 26505387 33 4471
2025-12-29 4 4 0001193125-25-335513 22982
2025-12-23 144 xsl144X01/primary_doc.xml 0001968582-25-001282 001-41562 251601881 33 4616
2025-12-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-308141 005-93833 251550152 34 15556
2025-12-02 144 xsl144X01/primary_doc.xml 0001193125-25-305720 001-41562 251544796 33 4661
2025-12-02 144 xsl144X01/primary_doc.xml 0001193125-25-305717 001-41562 251544793 33 4996
2025-12-02 144 xsl144X01/primary_doc.xml 0000950130-25-000295 001-41562 251544788 33 4641
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422849-25-000077 005-93833 251480400 34 7513
2025-11-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-272748 005-93833 251463978 34 15324
2025-11-05 10-Q 10-Q 0001193125-25-265796 001-41562 251451864 34 9469179 1 1
2025-11-05 8-K 8-K 2.02,7.01,9.01 0001193125-25-265800 001-41562 251451861 34 19139535 1 1
2025-11-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001231919-25-000416 005-93833 251450814 34 63782
2025-09-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-225170 005-93833 251361172 34 205827
2025-09-17 4 xslF345X05/form4-09172025_090930.xml 0001341382-25-000007 6950
2025-09-10 4 4 0000950170-25-114033 10648
2025-09-10 4 xslF345X05/form4-09102025_090907.xml 0001415889-25-024111 6949
2025-09-09 144 xsl144X01/primary_doc.xml 0001974494-25-000102 001-41562 251302366 33 5728
2025-09-05 4 4 0000950170-25-113276 4761
2025-09-04 4 4 0000950170-25-113088 7641
2025-09-03 144 xsl144X01/primary_doc.xml 0002004379-25-000005 001-41562 251287807 33 4967
2025-09-02 8-K 8-K 7.01,9.01 0000950170-25-112345 001-41562 251283093 34 18639353 1 1
2025-08-27 4 4 0000950170-25-111738 4986
2025-08-27 144 xsl144X01/primary_doc.xml 0002004379-25-000002 001-41562 251266211 33 4960
2025-08-25 4 4 0000950170-25-111241 9515
2025-08-25 144 xsl144X01/primary_doc.xml 0002056296-25-000009 001-41562 251251789 33 5703
2025-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-022506 005-93833 251237841 34 88670
2025-08-18 8-K 8-K 7.01,8.01,9.01 0000950170-25-109567 001-41562 251226305 34 255147 1 1
2025-08-15 8-K 8-K 1.01,9.01 0000950170-25-109387 001-41562 251224599 34 209755 1 1
2025-08-13 4 xslF345X05/form4-08132025_080851.xml 0001415889-25-021660 6950
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422849-25-000040 005-93833 251210206 34 7513
2025-08-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-107390 005-93833 251207216 34 145043
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-103520 001-41562 251187376 34 834907 1 1
2025-08-06 10-Q 10-Q 0000950170-25-103521 001-41562 251187373 34 8266314 1 1
2025-07-30 8-K 8-K 7.01,8.01,9.01 0000950170-25-099891 001-41562 251164069 34 10927591 1 1
2025-07-17 4 4 0000950170-25-096665 16233
2025-07-14 144 xsl144X01/primary_doc.xml 0001969223-25-000508 001-41562 251121855 33 5271
2025-07-11 8-K 8-K 5.02,9.01 0001193125-25-158211 001-41562 251119269 34 178594 1 1
2025-06-26 4 xslF345X05/form4-06262025_110648.xml 0001415889-25-018316 9329
2025-06-18 4 4 0000950170-25-087937 14733
2025-06-18 4 xslF345X05/form4-06182025_080636.xml 0001415889-25-017693 6951
2025-06-18 144 xsl144X01/primary_doc.xml 0001470831-25-000050 001-41562 251055927 33 4562
2025-06-11 8-K 8-K 7.01,9.01 0000950170-25-084663 001-41562 251038872 34 41345265 1 1
2025-06-09 8-K 8-K 7.01,8.01,9.01 0001193125-25-137432 001-41562 251032836 34 219569 1 1
2025-06-06 8-K 8-K 5.07,9.01 0001193125-25-137119 001-41562 251031283 34 204802 1 1
2025-06-03 4 4 0000950170-25-081087 7467
2025-06-03 4 4 0000950170-25-081072 7814
2025-06-03 3 3 0000950170-25-081069 23745
2025-05-19 4 4 0000950170-25-074463 9002
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013208 005-93833 25955047 34 20011
2025-05-15 144 xsl144X01/primary_doc.xml 0001968582-25-000363 001-41562 25954482 33 7928
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-25-000095 005-93833 25938256 34 7257
2025-05-08 ARS ARS 0001193125-25-116006 001-41562 25926718 34 10101604
2025-05-08 DEF 14A DEF 14A 0001193125-25-115995 001-41562 25926643 34 3333658 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066413 001-41562 25923958 34 8167572 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066410 001-41562 25923955 34 690123 1 1
2025-05-07 8-K 8-K 7.01,8.01,9.01 0001193125-25-114456 001-41562 25919313 34 242040 1 1
2025-05-02 4 4 0000950170-25-062897 5515
2025-05-02 4 4 0000950170-25-062894 7932
2025-04-28 PRE 14A PRE 14A 0001193125-25-100723 001-41562 25881202 34 3353176 1 1
2025-04-21 4 4 0000950170-25-056395 8287
2025-04-17 4 4 0000950170-25-055612 10792
2025-04-17 4 4 0000950170-25-055603 7306
2025-04-17 3 3 0000950170-25-055601 21987
2025-04-17 8-K 8-K 5.02,7.01,9.01 0001193125-25-084428 001-41562 25848219 34 214022 1 1
2025-04-11 144 xsl144X01/primary_doc.xml 0001973141-25-000177 001-41562 25833220 33 5267
2025-03-28 4 xslF345X05/form4-03282025_090345.xml 0001415889-25-009198 6950
2025-03-28 4 4 0000950170-25-046962 9506
2025-03-28 4 4 0000950170-25-046958 9728
2025-03-28 4 4 0000950170-25-046947 12045
2025-03-28 4 4 0000950170-25-046943 11421
2025-03-28 4 4 0000950170-25-046934 13450
2025-03-26 144 xsl144X01/primary_doc.xml 0001968582-25-000244 001-41562 25774649 33 4380
2025-03-26 144 xsl144X01/primary_doc.xml 0001968582-25-000242 001-41562 25774609 33 9046
2025-03-26 4 4 0000950170-25-045283 8536
2025-03-19 4 4 0000950170-25-042176 13160
2025-03-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000628 333-285462 25725689 33 1815
2025-03-10 424B3 424B3 0001193125-25-051062 333-285462 25724551 33 243208
2025-03-06 4 xslF345X05/form4-03062025_100302.xml 0001415889-25-007263 6958
2025-03-06 CORRESP filename1.htm 0001193125-25-048333 7608
2025-03-05 4 4 0000950170-25-033927 9066
2025-03-04 144 xsl144X01/primary_doc.xml 0002004379-25-000001 001-41562 25707517 33 4355
2025-03-04 UPLOAD filename1.pdf 0000000000-25-002386 333-285462 40161
2025-02-28 S-3 S-3 0001193125-25-042775 333-285462 25691988 33 1815898 1 1
2025-02-26 10-K 10-K 0000950170-25-027339 001-41562 25666221 34 18124540 1 1
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027336 001-41562 25666215 34 975212 1 1
2025-02-20 4 4 0000950170-25-024322 14559
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004299 005-93833 25631798 34 20065
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-25-000679 005-93833 25630303 34 38066
2025-01-31 4 4 0000950170-25-011854 16354
2025-01-29 4 4 0000950170-25-010594 17696
2025-01-29 4 4 0000950170-25-010575 18151
2025-01-27 144 xsl144X01/primary_doc.xml 0001968582-25-000053 001-41562 25560003 33 4613
2025-01-27 144 xsl144X01/primary_doc.xml 0001968582-25-000052 001-41562 25559852 33 4581
2025-01-10 144 xsl144X01/primary_doc.xml 0001973141-25-000014 001-41562 25523349 33 116101
2025-01-10 8-K 8-K 7.01,9.01 0001193125-25-004142 001-41562 25520563 34 14442597 1 1
2025-01-08 4 4 0000950170-25-003570 7334
2025-01-08 4 4 0000950170-25-003566 7287
2025-01-08 4 4 0000950170-25-003561 7253
2025-01-08 4 4 0000950170-25-003556 7350
2025-01-08 4 4 0000950170-25-003552 8267
2025-01-07 4 4 0000950170-25-003024 4979
2025-01-07 4 4 0000950170-25-003022 7361
2025-01-07 4 4 0000950170-25-003018 5054
2025-01-07 4 4 0000950170-25-002996 4993
2025-01-07 4 4 0000950170-25-002988 4962
2025-01-07 4 4 0000950170-25-002979 5026
2025-01-07 4 4 0000950170-25-002973 5002
2025-01-07 S-8 S-8 0001193125-25-002861 333-284166 25515201 33 259898 1 1
2025-01-06 4 4 0000950170-25-002374 5514
2025-01-06 4 4 0000950170-25-002372 5464
2025-01-06 4 4 0000950170-25-002370 5538
2025-01-06 4 4 0000950170-25-002369 5490
2025-01-06 4 4 0000950170-25-002363 5450
2025-01-06 4 4 0000950170-25-002356 5542
2025-01-02 4 4 0000950170-25-000445 14381
2024-12-30 4 4 0000950170-24-141146 16949
2024-12-26 4 4 0000950170-24-140408 22180
2024-12-20 4 4 0000950170-24-139069 19568
2024-12-18 4 4 0000950170-24-137893 18926
2024-12-17 SC 13D/A SC 13D/A 0001193125-24-280575 005-93833 241556916 34 169352
2024-12-17 4 4 0000950170-24-137335 41873
2024-12-17 SC 13D/A SC 13D/A 0001193125-24-280472 005-93833 241555566 34 96684
2024-12-17 SC 13D/A SC 13D/A 0001193125-24-280208 005-93833 241553965 34 335541
2024-12-16 4 4 0000950170-24-136642 19566
2024-12-13 8-K 8-K 1.01,7.01,9.01 0001193125-24-277937 001-41562 241546882 34 813463 1 1
2024-12-13 424B5 424B5 0001193125-24-277565 333-280687 241546732 33 752657
2024-12-12 4 4 0000950170-24-135796 24800
2024-12-11 S-3MEF S-3MEF 0001193125-24-276065 333-283740 241542890 33 176888
2024-12-10 424B5 424B5 0001193125-24-274386 333-280687 241539134 33 754240
2024-12-10 8-K 8-K 8.01 0001193125-24-274327 001-41562 241538425 34 186051 1 1
2024-12-10 8-K 8-K 7.01,9.01 0001193125-24-273959 001-41562 241537134 34 8099798 1 1
2024-11-20 8-K 8-K 7.01,8.01,9.01 0001193125-24-262125 001-41562 241478266 34 6160467 1 1
2024-11-19 4 4 0000950170-24-128607 16951
2024-11-18 8-K 8-K 7.01,8.01,9.01 0001193125-24-260923 001-41562 241471579 34 268673 1 1
2024-11-15 4 4 0000950170-24-127643 17090
2024-11-15 SC 13D/A SC 13D/A 0001193125-24-259852 005-93833 241468265 34 105749
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119286 005-93833 241464728 34 91995
2024-11-13 144 xsl144X01/primary_doc.xml 0001973141-24-000554 001-41562 241454693 33 4700
2024-11-06 10-Q 10-Q 0000950170-24-121828 001-41562 241429284 34 6413764 1 1
2024-11-06 8-K 8-K 2.02,9.01 0000950170-24-121827 001-41562 241429283 34 685730 1 1
2024-11-01 UPLOAD filename1.pdf 0000000000-24-012197 001-41562 39793
2024-10-28 20-F/A 20-F/A 0000950170-24-117574 001-41562 241398455 34 27363653 1 1
2024-10-18 8-K 8-K 4.02 0001193125-24-239687 001-41562 241381260 34 189497 1 1
2024-10-18 CORRESP filename1.htm 0001193125-24-239684 16228
2024-10-11 4 4 0000950170-24-114388 5110
2024-10-01 4 4 0000950170-24-110955 9058
2024-10-01 144 xsl144X01/primary_doc.xml 0002004379-24-000001 001-41562 241344317 33 4351
2024-09-30 4 4 0000950170-24-110440 4487
2024-09-30 UPLOAD filename1.pdf 0000000000-24-011067 001-41562 42707
2024-08-23 SC 13G/A SC 13G/A 0001193125-24-206196 005-93833 241236587 34 98323
2024-08-22 4 4 0000950170-24-099871 5843
2024-08-12 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-197977,2024-08-12 9999999995-24-002491 333-275932 241198605 33 1829
2024-08-09 POS AM POS AM 0001193125-24-197977 333-275932 241194104 33 22930
2024-08-09 8-K 8-K 8.01,9.01 0001193125-24-197971 001-41562 241194084 34 530730 1 1
2024-08-09 424B5 424B5 0001193125-24-197964 333-280687 241194049 33 587942
2024-08-08 CORRESP filename1.htm 0001193125-24-196905 54618
2024-08-07 10-Q 10-Q 0000950170-24-092281 001-41562 241181500 34 6534371 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092279 001-41562 241181494 34 628581 1 1
2024-07-29 8-K 8-K 7.01,8.01,9.01 0001193125-24-186747 001-41562 241149066 34 2476743 1 1
2024-07-25 UPLOAD filename1.pdf 0000000000-24-008468 001-41562 43293
2024-07-19 4 4 0000950170-24-084945 5400
2024-07-19 3 3 0000950170-24-084941 21044
2024-07-19 3 3 0000950170-24-084940 20640
2024-07-18 8-K 8-K 5.02,7.01,9.01 0001193125-24-180754 001-41562 241123735 34 227143 1 1
2024-07-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-12 09:00:00 9999999995-24-002157 333-280687 241115760 33 1816
2024-07-09 CORRESP filename1.htm 0001193125-24-176818 7475
2024-07-08 UPLOAD filename1.pdf 0000000000-24-007705 333-280687 40112
2024-07-03 S-8 S-8 0001193125-24-175076 333-280689 241100563 33 464821
2024-07-03 S-3 S-3 0001193125-24-175069 333-280687 241100531 33 1319129
2024-06-24 4 4 0000950170-24-076468 6407
2024-06-11 8-K 8-K 7.01,8.01,9.01 0001193125-24-158751 001-41562 241034637 34 216432 1 1
2024-06-07 8-K 8-K 5.07,8.01,9.01 0001193125-24-157374 001-41562 241029638 34 207794 1 1
2024-05-09 ARS ARS 0001193125-24-135293 001-41562 24930976 34 7020899
2024-05-09 DEF 14A DEF 14A 0001193125-24-135282 001-41562 24930863 34 848273
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056292 001-41562 24928661 34 529420 1 1
2024-05-08 10-Q 10-Q 0000950170-24-055767 001-41562 24926691 34 6072942 1 1
2024-05-03 3 3 0000950170-24-052925 20286
2024-04-29 PRE 14A PRE 14A 0001193125-24-122691 001-41562 24892300 34 848392
2024-04-19 424B3 424B3 0001193125-24-102926 333-275932 24858047 33 243764
2024-04-17 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-094677,2024-04-17 9999999995-24-001001 333-275932 24852691 33 1828
2024-04-12 POS AM POS AM 0001193125-24-094677 333-275932 24841628 33 784692
2024-04-02 4 4 0000950170-24-040235 5880
2024-04-01 8-K 8-K 5.02,7.01,9.01 0001193125-24-082723 001-41562 24805663 34 209193 1 1
2024-03-28 4 xslF345X05/form4-03282024_080315.xml 0001415889-24-009330 6420
2024-03-27 4 4 0000950170-24-037241 12448
2024-03-26 144 xsl144X01/primary_doc.xml 0001974158-24-000017 001-41562 24784924 33 5135
2024-03-12 424B3 424B3 0001193125-24-065893 333-268888 24742311 33 563147
2024-03-08 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-050794,2024-03-08 9999999995-24-000622 333-268888 24736428 33 1828
2024-03-04 8-K 8-K 7.01,9.01 0001193125-24-056922 001-41562 24712902 34 19323413 1 1
2024-03-01 SC 13D/A SC 13D/A 0001193125-24-056055 005-93833 24710412 34 116410
2024-02-28 POS AM POS AM 0001193125-24-050794 333-268888 24696563 33 792298
2024-02-28 8-K 8-K 2.02,9.01 0001193125-24-049263 001-41562 24690300 34 392496 1 1
2024-02-28 10-K 10-K 0000950170-24-021668 001-41562 24690234 34 16504523 1 1
2024-02-21 4 4 0000950170-24-018045 4849
2024-02-21 SC 13D/A SC 13D/A 0001193125-24-040964 005-93833 24657164 34 328597
2024-02-15 8-K 8-K 1.01,7.01,9.01 0001193125-24-037559 001-41562 24644054 34 732275 1 1
2024-02-15 424B5 424B5 0001193125-24-037547 333-275932 24643981 33 1204292
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024010 005-93833 24640141 34 91191
2024-02-14 SC 13G/A sayw24021414_13ga.htm 0000905148-24-000615 005-93833 24633539 34 401437
2024-02-13 424B5 424B5 0001193125-24-033967 333-275932 24630057 33 1207674
2024-01-25 3/A 3/A 0000950170-24-007483 4501
2024-01-25 3/A 3/A 0000950170-24-007482 8874
2024-01-22 8-K 8-K 7.01,9.01 0001193125-24-011701 001-41562 24547116 34 19453529 1 1
2024-01-08 4 4 0000950170-24-003155 5369
2024-01-08 3 3 0000950170-24-003151 2960
2024-01-08 8-K 8-K 5.02,7.01,9.01 0001193125-24-003956 001-41562 24518472 34 18042593 1 1
2024-01-04 8-K 8-K 7.01,9.01 0001193125-24-001933 001-41562 24509804 34 218419 1 1
2024-01-03 4 4 0000950170-24-001166 5470
2024-01-03 4 4 0000950170-24-001141 5517
2024-01-03 4 4 0000950170-24-001133 5462
2024-01-03 4 4 0000950170-24-001128 5378
2024-01-03 4 4 0000950170-24-001125 5545
2024-01-03 4 4 0000950170-24-001116 5505
2024-01-03 4 4 0000950170-24-001112 5447
2024-01-03 4 4 0000950170-24-001104 5490
2024-01-02 3 3 0000950170-24-000235 13057
2023-12-29 3 FORM 3 SUBMISSION 0000899243-23-020705 24080
2023-12-29 3 3 0000950170-23-073906 2994
2023-12-29 3 3 0000950170-23-073866 17172
2023-12-29 3 3 0000950170-23-073867 18515
2023-12-29 3 3 0000950170-23-073863 7849
2023-12-29 3 3 0000950170-23-073864 24575
2023-12-29 3 3 0000950170-23-073856 23982
2023-12-29 3 3 0000950170-23-073859 24731
2023-12-29 3 3 0000950170-23-073862 17345
2023-12-29 3 3 0000950170-23-073861 22464
2023-12-29 3 3 0000950170-23-073858 24853
2023-12-29 3 3 0000950170-23-073860 19721
2023-12-29 3 3 0000950170-23-073855 20351
2023-12-19 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2023-12-19 16:00:00 9999999995-23-003688 333-275932 231499218 33 1816
2023-12-19 424B3 424B3 0001193125-23-298655 333-275932 231497877 33 332105
2023-12-15 CORRESP filename1.htm 0001193125-23-296402 7599
2023-12-15 UPLOAD filename1.pdf 0000000000-23-013686 40347
2023-12-07 F-3 F-3 0001193125-23-290704 333-275932 231472571 33 1880816
2023-11-13 424B3 424B3 0001193125-23-275415 333-268888 231395361 33 19827
2023-11-13 6-K 6-K 0001193125-23-275412 001-41562 231395350 34 49442
2023-10-23 6-K 6-K 0001193125-23-260375 001-41562 231338565 34 23705
2023-09-25 6-K 6-K 0001193125-23-240939 001-41562 231273157 34 15753557
2023-09-21 424B3 424B3 0001193125-23-239086 333-268888 231267731 33 24666
2023-09-21 6-K 6-K 0001193125-23-239082 001-41562 231267727 34 38027
2023-09-20 SC 13G/A SC 13G/A 0001193125-23-237890 005-93833 231265172 34 112462
2023-08-28 6-K 6-K 0001193125-23-222609 001-41562 231215716 34 6386135
2023-08-15 424B3 424B3 0001193125-23-213502 333-268888 231175535 33 7474217
2023-08-15 SC 13D/A SC 13D/A 0001193125-23-213432 005-93833 231174834 34 353710
2023-08-14 6-K 6-K 0001193125-23-212443 001-41562 231171562 34 15167912
2023-08-11 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-204488,2023-08-11 9999999995-23-002352 333-268888 231165939 33 1780
2023-08-07 POS AM POS AM 0001193125-23-204488 333-268888 231145640 33 22216766 1 1
2023-08-07 6-K 6-K 0001193125-23-204473 001-41562 231145610 34 112180
2023-08-07 6-K 6-K 0000950170-23-038741 001-41562 231145584 34 8758493 1 1
2023-08-01 SC 13G/A SC 13G/A 0001104659-23-086394 005-93833 231132174 34 86140
2023-07-26 6-K 6-K 0001193125-23-194094 001-41562 231110088 34 27278
2023-07-07 SC 13D/A SC 13D/A 0001193125-23-183874 005-93833 231077556 34 207021
2023-07-07 SC 13D SC 13D 0001193125-23-183868 005-93833 231077513 34 184463
2023-06-21 424B3 424B3 0001193125-23-171141 333-268888 231029788 33 32492
2023-06-21 6-K 6-K 0001193125-23-171138 001-41562 231029769 34 26855
2023-06-20 SC 13G SC 13G 0001140361-23-030497 005-93833 231025628 34 397121
2023-06-13 SC 13D/A SC 13D/A 0001193125-23-166095 005-93833 231012050 34 125941
2023-06-12 424B3 424B3 0001193125-23-164677 333-268888 231006965 33 577524
2023-06-12 6-K 6-K 0001193125-23-164675 001-41562 231006963 34 572079
2023-06-09 SC 13D/A SC 13D/A 0001193125-23-164408 005-93833 231005065 34 336345
2023-06-08 424B3 424B3 0001193125-23-163591 333-268888 231002756 33 12613441
2023-06-06 424B3 424B3 0001193125-23-161639 333-268888 23996348 33 12595230
2023-06-05 6-K 6-K 0001193125-23-160369 001-41562 23991354 34 12766666
2023-05-31 6-K 6-K 0001193125-23-157287 001-41562 23978994 34 55843
2023-05-23 424B3 424B3 0001193125-23-151162 333-268888 23946572 33 29911
2023-05-23 6-K 6-K 0001193125-23-151160 001-41562 23946568 34 24376
2023-05-08 424B3 424B3 0001193125-23-137723 333-268888 23895979 33 42265
2023-05-08 6-K 6-K 0001193125-23-137718 001-41562 23895969 34 36672
2023-04-25 424B3 424B3 0001193125-23-114229 333-268888 23841841 33 6646705
2023-04-24 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-102996,2023-04-24 9999999995-23-001026 333-268888 23841512 33 1779
2023-04-24 6-K 6-K 0001193125-23-111816 001-41562 23837980 34 27829
2023-04-17 POS AM POS AM 0001193125-23-102996 333-268888 23823008 33 6779126
2023-04-03 6-K FORM 6-K 0001193125-23-088965 001-41562 23790746 34 23613
2023-03-31 20-F 20-F 0000950170-23-011412 001-41562 23788357 34 31500463 1 1
2023-03-31 6-K 6-K 0001193125-23-086865 001-41562 23783462 34 101080
2023-03-31 S-8 S-8 0001193125-23-086736 333-271019 23783248 33 464476
2023-03-07 6-K 6-K 0001193125-23-062164 001-41562 23711096 34 22045383
2023-03-03 6-K 6-K 0001193125-23-060135 001-41562 23705211 34 9677
2023-02-14 6-K 6-K 0001193125-23-037365 001-41562 23622751 34 18295926
2023-02-06 6-K 6-K 0001193125-23-024918 001-41562 23588438 34 23005
2023-01-31 424B3 424B3 0001193125-23-020321 333-268888 23572537 33 9671012
2023-01-30 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2023-01-30 16:00:00 9999999995-23-000220 333-268888 23570108 33 1766
2023-01-26 CORRESP filename1.htm 0001193125-23-016222 6998
2023-01-17 6-K 6-K 0001193125-23-008951 001-41562 23530319 34 28111
2023-01-17 CORRESP filename1.htm 0001193125-23-008949 52803
2023-01-17 F-1/A F-1/A 0001193125-23-008945 333-268888 23530305 33 9971210
2023-01-11 6-K 6-K 0001193125-23-006539 001-41562 23524145 34 9733
2023-01-09 6-K FORM 6-K 0001193125-23-004215 001-41562 23516749 34 19283465
2023-01-05 UPLOAD filename1.pdf 0000000000-23-000172 46458
2022-12-20 F-1 F-1 0001193125-22-308510 333-268888 221472353 33 10415503
2022-12-19 6-K 6-K 0001193125-22-308349 001-41562 221471386 34 183144
2022-12-02 SC 13G SC 13G 0001104659-22-124124 005-93833 221442380 34 77716
2022-12-02 SC 13D SC 13D 0001193125-22-297559 005-93833 221442264 34 121240
2022-12-02 SC 13G SC 13G 0001193125-22-297529 005-93833 221441944 34 115056
2022-12-02 SC 13G SC 13G 0001193125-22-296843 005-93833 221440196 34 101977
2022-12-02 SC 13D SC 13D 0001193125-22-296700 005-93833 221439751 34 375636
2022-11-28 20-F 20-F 0001193125-22-293435 001-41562 221426053 34 792716
2022-11-23 6-K 6-K 0001193125-22-292064 001-41562 221416787 34 663588
2022-11-22 CERT 8A_Cert_NAMS.pdf 0001354457-22-000659 001-41562 221408029 34 219582
2022-11-22 8-A12B 8-A12B 0001193125-22-290157 001-41562 221407157 34 15393
2022-11-18 8-A12B 8-A12B 0001193125-22-289122 001-41562 221402821 34 15585
2022-11-16 425 425 0001193125-22-286672 333-266510 221394700 34 48806
2022-10-19 SEC STAFF LETTER filename1.pdf 9999999997-22-004559 275143
2022-10-18 EFFECT xslEFFECTX01/primary_doc.xml F-4,,2022-10-18 16:00:00 9999999995-22-003068 333-266510 221317144 33 1663
2022-10-18 424B3 424B3 0001193125-22-264479 333-266510 221316333 33 8866567
2022-10-17 425 425 0001193125-22-263757 333-266510 221314111 34 242375
2022-10-14 CORRESP filename1.htm 0001193125-22-263019 6790
2022-10-13 CORRESP filename1.htm 0001193125-22-262261 27282
2022-10-13 F-4/A F-4/A 0001193125-22-262258 333-266510 221309691 33 8976941
2022-10-13 425 425 0001193125-22-262239 50699
2022-10-12 UPLOAD filename1.pdf 0000000000-22-011222 44515
2022-10-11 425 425 0001193125-22-260107 47511
2022-10-05 425 425 0001193125-22-258209 51381
2022-10-05 425 425 0001193125-22-258204 24007
2022-10-04 425 425 0001193125-22-257602 38876
2022-10-03 CORRESP filename1.htm 0001193125-22-256786 66895
2022-10-03 F-4/A F-4/A 0001193125-22-256774 333-266510 221288420 33 10244362
2022-09-29 425 425 0001193125-22-254392 46405
2022-09-28 425 425 0001193125-22-253405 43753
2022-09-27 UPLOAD filename1.pdf 0000000000-22-010640 53261
2022-09-23 425 425 0001193125-22-250161 57329
2022-09-22 425 425 0001193125-22-249188 72142
2022-09-21 425 425 0001193125-22-248086 22700477
2022-09-20 425 425 0001193125-22-247715 44635
2022-09-13 CORRESP filename1.htm 0001193125-22-243789 75205

Latest XBRL company facts

One latest value per concept from companyfacts (295 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 119.93M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
dei EntityPublicFloat Entity Public Float USD 1.35B 2025-06-30 2025 FY 10-K 2026-02-18 0001193125-26-056029
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 9.34M 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 4.30M 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 135.46 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 30.50M 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ecd PeoTotalCompAmt PeoTotalCompAmt USD 13.64M 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 321.83 2025-01-01 2025-12-31 DEF 14A 2026-05-06 0001193125-26-207562
ifrs-full AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome EUR -119.36M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets EUR 172,000 2021-01-01 2021-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 11.09M 2021-01-01 2021-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables EUR -3.98M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable EUR -115.00M 2022-01-01 2022-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full AdjustmentsForDepreciationAndAmortisationExpense AdjustmentsForDepreciationAndAmortisationExpense EUR 72,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForFairValueGainsLosses AdjustmentsForFairValueGainsLosses EUR 976,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForIncreaseDecreaseInOtherOperatingPayables AdjustmentsForIncreaseDecreaseInOtherOperatingPayables EUR -2.06M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments EUR 3.92M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AdjustmentsForUnrealisedForeignExchangeLossesGains AdjustmentsForUnrealisedForeignExchangeLossesGains EUR 9.26M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full AmountsReceivableRelatedPartyTransactions AmountsReceivableRelatedPartyTransactions EUR 718,000 2021-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full Assets Assets EUR 531.58M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full BalancesWithBanks BalancesWithBanks EUR 438.52M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare EUR/shares -1.97 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full Cash Cash EUR 438.52M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CashAndCashEquivalents CashAndCashEquivalents EUR 438.52M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities EUR 375.18M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities EUR 715,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities EUR 7.97M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ComprehensiveIncome ComprehensiveIncome EUR -78.05M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ContractLiabilities ContractLiabilities EUR 4.60M 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full CurrentAssets CurrentAssets EUR 448.13M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CurrentLeaseLiabilities CurrentLeaseLiabilities EUR 62,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CurrentLiabilities CurrentLiabilities EUR 35.46M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CurrentPrepayments CurrentPrepayments EUR 7.67M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CurrentValueAddedTaxPayables CurrentValueAddedTaxPayables EUR 2.77M 2021-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full CurrentValueAddedTaxReceivables CurrentValueAddedTaxReceivables EUR 1.94M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full DeferredTaxAssets DeferredTaxAssets USD 0 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full DepreciationAndAmortisationExpense DepreciationAndAmortisationExpense EUR 72,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full DepreciationRightofuseAssets DepreciationRightofuseAssets EUR 64,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full DilutedEarningsLossPerShare DilutedEarningsLossPerShare EUR/shares -1.97 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares shares 11.15M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents EUR 1.57M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full EmployeeBenefitsExpense EmployeeBenefitsExpense EUR 11.77M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full Equity Equity EUR 484.52M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full EquityAndLiabilities EquityAndLiabilities EUR 531.58M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ExercisePriceShareOptionsGranted2019 ExercisePriceShareOptionsGranted2019 EUR/shares 9.73 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted pure 0 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ExpenseFromSharebasedPaymentTransactionsWithEmployees ExpenseFromSharebasedPaymentTransactionsWithEmployees EUR 3.92M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full FeeAndCommissionExpense FeeAndCommissionExpense EUR 2.48M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full FinanceCosts FinanceCosts EUR 271,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full FinanceIncome FinanceIncome EUR 11,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full FinancialLiabilities FinancialLiabilities EUR 29.56M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationBeforeTax GainsLossesOnExchangeDifferencesOnTranslationBeforeTax EUR -9.26M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges EUR 383.86M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxEntitysOwnEquityInstruments IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxEntitysOwnEquityInstruments EUR -3.53M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxEntitysOwnEquityInstruments IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxEntitysOwnEquityInstruments EUR -3.53M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseInLiabilitiesArisingFromFinancingActivities IncreaseDecreaseInLiabilitiesArisingFromFinancingActivities EUR 10.96M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities EUR 976,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseThroughConversionOfConvertibleInstruments IncreaseDecreaseThroughConversionOfConvertibleInstruments EUR 11.67M 2021-01-01 2021-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities EUR -370,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseThroughExerciseOfOptions IncreaseDecreaseThroughExerciseOfOptions EUR 96,000 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity EUR 9.42M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities EUR -65,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions EUR 4.10M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full InsuranceExpense InsuranceExpense EUR 289,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IntangibleAssetsOtherThanGoodwill IntangibleAssetsOtherThanGoodwill EUR 83.16M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities EUR 9,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full InterestPaidClassifiedAsFinancingActivities InterestPaidClassifiedAsFinancingActivities EUR 9,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full InterestPaidClassifiedAsOperatingActivities InterestPaidClassifiedAsOperatingActivities EUR 262,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full InterestReceivedClassifiedAsInvestingActivities InterestReceivedClassifiedAsInvestingActivities EUR 5.18M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full IssuedCapital IssuedCapital EUR 599.19M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full IssuedCapitalOrdinaryShares IssuedCapitalOrdinaryShares EUR 280,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation USD 5,944 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment USD 3,203 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full KeyManagementPersonnelCompensationShorttermEmployeeBenefits KeyManagementPersonnelCompensationShorttermEmployeeBenefits USD 2,741 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full LeaseLiabilities LeaseLiabilities EUR 118,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full LiabilitiesArisingFromFinancingActivities LiabilitiesArisingFromFinancingActivities EUR 11.06M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full LiabilitiesFromSharebasedPaymentTransactions2011 LiabilitiesFromSharebasedPaymentTransactions2011 EUR 1.94M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full MiscellaneousOtherOperatingExpense MiscellaneousOtherOperatingExpense EUR 0 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NoncurrentAssets NoncurrentAssets EUR 83.45M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NoncurrentLeaseLiabilities NoncurrentLeaseLiabilities EUR 56,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NoncurrentLiabilities NoncurrentLiabilities EUR 11.60M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfInstrumentsOtherEquityInstrumentsGranted NumberOfInstrumentsOtherEquityInstrumentsGranted shares 0 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement shares 608,779 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfOutstandingShareOptions NumberOfOutstandingShareOptions shares 11.15M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfShareOptionsExercisableInSharebasedPaymentArrangement NumberOfShareOptionsExercisableInSharebasedPaymentArrangement shares 2.84M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfShareOptionsExercisedInSharebasedPaymentArrangement NumberOfShareOptionsExercisedInSharebasedPaymentArrangement shares 14,910 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement shares 1.72M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full NumberOfShareOptionsGrantedInSharebasedPaymentArrangement NumberOfShareOptionsGrantedInSharebasedPaymentArrangement shares 6.96M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full NumberOfSharesOutstanding NumberOfSharesOutstanding shares 81.56M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full OperatingExpense OperatingExpense EUR 165.06M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full OtherComprehensiveIncome OtherComprehensiveIncome EUR -8.88M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full OtherLongtermBenefits OtherLongtermBenefits EUR 832,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full OtherReserves OtherReserves EUR 4.69M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ParValuePerShare ParValuePerShare EUR/shares 0.12 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full PaymentsForShareIssueCosts PaymentsForShareIssueCosts EUR 2.53M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities EUR 65,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full PostemploymentBenefitExpenseDefinedContributionPlans PostemploymentBenefitExpenseDefinedContributionPlans EUR 66,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProceedsFromBorrowingsClassifiedAsFinancingActivities ProceedsFromBorrowingsClassifiedAsFinancingActivities EUR 11.32M 2020-01-01 2020-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants EUR 8.00M 2023-01-01 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares EUR 160.00M 2021-01-07 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProfitLoss ProfitLoss EUR -78.05M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProfitLossAttributableToOwnersOfParent ProfitLossAttributableToOwnersOfParent EUR -78.05M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax EUR -78.05M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities EUR -67.56M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment EUR 144,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities EUR 13,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax EUR 8.88M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full RentDeferredIncomeClassifiedAsCurrent RentDeferredIncomeClassifiedAsCurrent EUR 13.01M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full RentDeferredIncomeClassifiedAsNoncurrent RentDeferredIncomeClassifiedAsNoncurrent EUR 4.49M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full RepaymentsOfBorrowingsClassifiedAsFinancingActivities RepaymentsOfBorrowingsClassifiedAsFinancingActivities EUR 728,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense EUR 82.23M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full RevenueFromContractsWithCustomers RevenueFromContractsWithCustomers EUR 97.50M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full RightofuseAssets RightofuseAssets EUR 113,000 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full SellingGeneralAndAdministrativeExpense SellingGeneralAndAdministrativeExpense EUR 22.23M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full SharePremium SharePremium EUR 589.40M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense EUR 20.09M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate EUR 20.09M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TaxRateEffectFromChangeInTaxRate TaxRateEffectFromChangeInTaxRate pure 0 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables EUR 18.50M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TradeAndOtherPayables TradeAndOtherPayables EUR 16.57M 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TransportationExpense TransportationExpense EUR 3.02M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full TravelExpense TravelExpense EUR 430,000 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WagesAndSalaries WagesAndSalaries EUR 7.01M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 EUR/shares 6.89 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 EUR/shares 9.96 2023-01-01 2023-06-30 2023 Q2 6-K 2023-08-07 0000950170-23-038741
ifrs-full WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 USD/shares 10 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 EUR/shares 6.52 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WeightedAverageFairValueAtMeasurementDateShareOptionsGranted WeightedAverageFairValueAtMeasurementDateShareOptionsGranted EUR 4.2 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WeightedAverageSharePriceShareOptionsGranted2019 WeightedAverageSharePriceShareOptionsGranted2019 EUR/shares 9.61 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
ifrs-full WeightedAverageShares WeightedAverageShares shares 39.63M 2022-01-01 2022-12-31 2022 FY 20-F/A 2024-10-28 0000950170-24-117574
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 15.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 7.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 3.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.50B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 12.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD -5.79M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 48.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 155,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021668
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD -43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 22.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap Assets Assets USD 687.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap AssetsCurrent Assets, Current USD 672.16M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap Cash Cash USD 771.70M 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 423.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 424.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -64.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share EUR/shares 0.12 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 119.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 119.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap CommonStockValue Common Stock, Value, Issued USD 15.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -131.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210272
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 12.95M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021668
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap DeferredRevenue Deferred Revenue USD 5.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 5.71M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 1.02M 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 217.05M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 22.88M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 43,000 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 128.87M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 135,000 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 217.00M 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 226,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333824
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 188,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 31.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 7.79M 2023-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.258 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.11 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure -0.002 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.075 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.008 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 6.20M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-07 0000950170-24-092281
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -2.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -18,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333824
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -883,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-021668
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -57.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -128.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -146.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 22.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 2.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -52.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 15.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -1.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -2.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -4.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 312,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap InterestExpense Interest Expense USD 287,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 277,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 16.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 39.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap Liabilities Liabilities USD 57.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 687.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap LiabilitiesCurrent Liabilities, Current USD 57.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ManufacturingCosts Manufacturing Costs USD 13.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 205.11M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 14.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 27.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 17.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -109.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -129.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 4.01M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OperatingExpenses Operating Expenses USD 193.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -167.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 49,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 75,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 11.13M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 8.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.59M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 989,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 193.34M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0000950170-25-103521
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 126.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 295,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 42.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 2.58M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210272
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity EUR 160.00M 2021-01-07 2023 FY 10-K 2024-02-28 0000950170-24-021668
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 37.16M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0000950170-25-103521
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 144.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 26.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 799,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -129.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 554,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 119.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -892.36M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 25.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 562,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265796
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 74.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 48.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 89,405 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 31.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 546,190 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 34.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 945,284 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 30.11 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 239,784 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 25.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0000950170-25-103521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.523 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 133.59M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 11.43M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.83 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 87.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 676,939 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 168.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 18.92M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.94 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 608,779 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 20.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.85 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 26.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 34.61 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 630.78M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 3.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.47M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 84.54M 2021-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 6.04M 2021-12-31 2024 FY 10-K 2025-02-26 0000950170-25-027339
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-18 0001193125-26-056029
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 303,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 123.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 123.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-446228

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →